BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22245693)

  • 1. Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells.
    Li W; Yuan Y; Huang L; Qiao M; Zhang Y
    Diabetes Res Clin Pract; 2012 May; 96(2):187-95. PubMed ID: 22245693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells.
    Li WG; Yuan YZ; Qiao MM; Zhang YP
    World J Gastroenterol; 2012 Jun; 18(21):2630-9. PubMed ID: 22690071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
    Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C
    Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer.
    Ikeda Y; Tanji E; Makino N; Kawata S; Furukawa T
    Mol Cancer Res; 2012 Feb; 10(2):259-69. PubMed ID: 22188669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.
    Bao B; Wang Z; Ali S; Ahmad A; Azmi AS; Sarkar SH; Banerjee S; Kong D; Li Y; Thakur S; Sarkar FH
    Cancer Prev Res (Phila); 2012 Mar; 5(3):355-64. PubMed ID: 22086681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.
    Jia Y; Liu H; Zhuang Q; Xu S; Yang Z; Li J; Lou J; Zhang W
    Oncol Rep; 2012 Jun; 27(6):1865-72. PubMed ID: 22378186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
    Zhao XX; Yuan QZ; Mu DP; Sun DW; Bo QA; Pan GZ; Li GQ; Cui T; Ding PP; You FP; Hao L; Wang MX; Zhang J
    Int J Clin Exp Pathol; 2015; 8(1):368-73. PubMed ID: 25755724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
    Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
    Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells.
    Laurila EM; Sandström S; Rantanen LM; Autio R; Kallioniemi A
    Genes Chromosomes Cancer; 2012 Jun; 51(6):557-68. PubMed ID: 22344632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially expressed microRNAs in pancreatic cancer stem cells.
    Jung DE; Wen J; Oh T; Song SY
    Pancreas; 2011 Nov; 40(8):1180-7. PubMed ID: 21785383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.
    Lin Y; Chen H; Hu Z; Mao Y; Xu X; Zhu Y; Xu X; Wu J; Li S; Mao Q; Zheng X; Xie L
    FEBS Lett; 2013 Aug; 587(15):2467-73. PubMed ID: 23796420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulatory roles of miRNA and methylation on oncogene and tumor suppressor gene expression in pancreatic cancer cells.
    Wang X; Zhao J; Huang J; Tang H; Yu S; Chen Y
    Biochem Biophys Res Commun; 2012 Aug; 425(1):51-7. PubMed ID: 22820191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ski acts as therapeutic target of qingyihuaji formula in the treatment of SW1990 pancreatic cancer.
    Wang P; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Liu LM
    Integr Cancer Ther; 2010 Mar; 9(1):50-8. PubMed ID: 20308085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of microRNAs regulated by activin A in human embryonic stem cells.
    Tsai ZY; Singh S; Yu SL; Kao LP; Chen BZ; Ho BC; Yang PC; Li SS
    J Cell Biochem; 2010 Jan; 109(1):93-102. PubMed ID: 19885849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide.
    Jiang Y; Wu Y; Greenlee AR; Wu J; Han Z; Li X; Zhao Y
    Toxicol Sci; 2011 Jan; 119(1):50-60. PubMed ID: 20889678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
    Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
    Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D
    Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of A549 lung cancer tumors by anti-miR-150 vector.
    Li YJ; Zhang YX; Wang PY; Chi YL; Zhang C; Ma Y; Lv CJ; Xie SY
    Oncol Rep; 2012 Jan; 27(1):129-34. PubMed ID: 21935578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.